Literature DB >> 26942278

2015 William Allan Award.

Kay E Davies1.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 26942278      PMCID: PMC4800040          DOI: 10.1016/j.ajhg.2016.01.007

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  80 in total

1.  Microtubules underlie dysfunction in duchenne muscular dystrophy.

Authors:  Ramzi J Khairallah; Guoli Shi; Francesca Sbrana; Benjamin L Prosser; Carlos Borroto; Mark J Mazaitis; Eric P Hoffman; Anup Mahurkar; Fredrick Sachs; Yezhou Sun; Yi-Wen Chen; Roberto Raiteri; W Jonathan Lederer; Susan G Dorsey; Christopher W Ward
Journal:  Sci Signal       Date:  2012-08-07       Impact factor: 8.192

2.  X-ROS signaling: rapid mechano-chemo transduction in heart.

Authors:  Benjamin L Prosser; Christopher W Ward; W J Lederer
Journal:  Science       Date:  2011-09-09       Impact factor: 47.728

3.  Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy.

Authors:  A E Deconinck; J A Rafael; J A Skinner; S C Brown; A C Potter; L Metzinger; D J Watt; J G Dickson; J M Tinsley; K E Davies
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

Review 4.  Progress and prospects of gene therapy clinical trials for the muscular dystrophies.

Authors:  Niclas E Bengtsson; Jane T Seto; John K Hall; Jeffrey S Chamberlain; Guy L Odom
Journal:  Hum Mol Genet       Date:  2015-10-08       Impact factor: 6.150

Review 5.  The Pathogenesis and Therapy of Muscular Dystrophies.

Authors:  Simon Guiraud; Annemieke Aartsma-Rus; Natassia M Vieira; Kay E Davies; Gert-Jan B van Ommen; Louis M Kunkel
Journal:  Annu Rev Genomics Hum Genet       Date:  2015-06-04       Impact factor: 8.929

6.  Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse.

Authors:  Jonathon M Tinsley; Rebecca J Fairclough; Richard Storer; Fraser J Wilkes; Allyson C Potter; Sarah E Squire; Dave S Powell; Anna Cozzoli; Roberta F Capogrosso; Adam Lambert; Francis X Wilson; Stephen P Wren; Annamaria De Luca; Kay E Davies
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

7.  Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.

Authors:  Aurélie Goyenvalle; Arran Babbs; Jordan Wright; Vivienne Wilkins; Dave Powell; Luis Garcia; Kay E Davies
Journal:  Hum Mol Genet       Date:  2012-03-02       Impact factor: 6.150

8.  Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice.

Authors:  A E Deconinck; A C Potter; J M Tinsley; S J Wood; R Vater; C Young; L Metzinger; A Vincent; C R Slater; K E Davies
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539

9.  Second-generation compound for the modulation of utrophin in the therapy of DMD.

Authors:  Simon Guiraud; Sarah E Squire; Benjamin Edwards; Huijia Chen; David T Burns; Nandini Shah; Arran Babbs; Stephen G Davies; Graham M Wynne; Angela J Russell; David Elsey; Francis X Wilson; Jon M Tinsley; Kay E Davies
Journal:  Hum Mol Genet       Date:  2015-05-01       Impact factor: 6.150

Review 10.  Advances in genetic therapeutic strategies for Duchenne muscular dystrophy.

Authors:  Simon Guiraud; Huijia Chen; David T Burns; Kay E Davies
Journal:  Exp Physiol       Date:  2015-08-04       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.